Ilyang Pharm obtains US patent related to peptide to treat inflammatory diseases

10:51
Opposition leader faces sentencing hearing over allegedly suborning perjury this week
10:06
golden horse caption
09:41
Japan voices regret over S. Korea's non-attendance of Sado memorial
16:13
S. Korea not to attend Sado mine memorial: foreign ministry
16:01
Gyeongju blends old with new
16:01
[What to Play] Cozy songs to warm you up
16:01
[Weekender] Korea's traditional sauce culture gains global recognition
16:01
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
16:01
At Gwangcheonok, try North Korean-style sundae gukbap
16:01
Over 80,000 malicious calls made to Seoul call center since 2020

Ilyang Pharm obtains US patent related to peptide to treat inflammatory diseases

June 29, 2016 - 10:19 By 황유미

[DISCLOSURE] Ilyang Pharmaceutical (007570) has obtained a US patent related to peptide to treat immune or inflammatory diseases, it announced on June 29.

황유미